​

Funding Round

Series A - PMV Pharmaceuticals

Series A - PMV Pharmaceuticals

Investment Firm

Overview

PMV Pharmaceuticals is a developer of p53-targeted small molecule drugs for the treatment of cancer.

Announced Date

Dec 02, 2014

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

OrbiMed

OrbiMed

OrbiMed is a debt and early_stage_venture and late_stage_venture and post_ipo and private_equity and seed and venture firm.

Participant Investors

3

Investor Name
Participant InvestorOrbiMed
Participant InvestorInterWest Partners
Participant InvestorOUP (Osage University Partners)

Round Details and Background

PMV Pharmaceuticals raised $30000000 on 2014-12-02 in Series A

PMV Pharmaceuticals is a developer of p53-targeted small molecule drugs for the treatment of cancer.

Company Funding History

4

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Nov 13, 2019
Series C - PMV Pharmaceuticals
8-62.0M
Aug 03, 2020
Series D - PMV Pharmaceuticals
7-70.0M
Feb 22, 2017
Series B - PMV Pharmaceuticals
5-74.0M
Dec 02, 2014
Series A - PMV Pharmaceuticals
3-30.0M

Recent Activity

There is no recent news or activity for this profile.